Frédéric Schlemmer

MD PhD, pulmonologist @APHP @GHUMondor @UPECactus @IMRB_Mondor #GEIC2Olab🦎

[Dr Jérôme BARRIERE, MD. @barriere_dr]

🗣️Tribune dans @le_Parisien : « Notre devons rendre disponible la vaccination contre le VRS chez les personnes à risque dès cette année »

Voici pourquoi : nous avons un vaccin et ce virus peut être aussi mortel que la grippe !

https://t.co/vxAJwvt7Qs

1/⤵️

[NEJM @NEJM]

A 55-year-old man with acute myeloid leukemia presented with dyspnea, cough, and hypoxemia 17 days after undergoing myeloablative allogeneic stem-cell transplantation. Videos show the results of chest CT imaging. Read the full case: https://t.co/w4GuE2SsEg

[CHEST @accpchest]

Diagnosis and Management of Myositis-Associated Lung Disease. Read the full #CHESTReview in the June @journal_CHEST issue: https://t.co/FoGQ5Y9kRK
#MedEd #MedTwitter

[Société de Pneumologie de Langue Française (SPLF) @SPLF_SocPneumo]

C’est la semaine de la vaccination !
Votre patient est-il bien protégé contre les infections respiratoires ?
Quels vaccins lui proposer ?
👉https://t.co/l8cCpmnAmv
@G2A_SPLF @blanchardelodi4 @ajpo2 @PneumoCphg @RespiFIL @GAVSPLF @PneumoCphg

[The Lancet Respiratory Medicine @LancetRespirMed]

NEW Research—#Bronchiectasis shows important geographical variation in causes, microbiology, severity, and outcomes across Europe

Read the EMBARC study here https://t.co/mnBV4FEkI1

[James D Chalmers @ProfJDChalmers]

Bronchiectasis in Europe- Data from the EMBARC registry. Just published in @LancetRespirMed our prospective study of 16963 patients from 28 countries describing characteristics and outcomes of bronchiectasis.
@EuroRespSoc @AlibertiStefano @EvaPolverino
https://t.co/SjCYnVyInB

[Frédéric Schlemmer @fred_schlemmer]

🙏 @FduSouffle for support ! @SPLF_SocPneumo

[ERS publications @ERSpublications]

ERJ: Among a cohort of 485 survivors of severe-to-critical COVID-19, including non-ICU patients, most recovered well but a high percentage had residual radiological and functional sequelae, and residual symptoms up to 1 year, justifying prolonged follow-up https://t.co/PMYFAeciCZ

[Montani David @Montanidavid]

Psychological burden on tenured university hospital faculty staff in France is considerable. Health care authorities should urgently develop strategies for burden prevention and alleviation and for attraction of the next generation @SPLF_SocPneumo
https://t.co/WTcI5JVOsQ

[Société de Pneumologie de Langue Française (SPLF) @SPLF_SocPneumo]

Le Professeur Anh-Tuan Dinh-Xuan, physiologiste à l’Hôpital Cochin, Paris, s’est présenté pour le poste de Vice-Président de l’ERS, (qui deviendra Président de l’ERS). Votons tous pour lui! https://t.co/WH81dW9Tci..ça prend 2 minutes!

[Frédéric Schlemmer @fred_schlemmer]

@macromik 2ème option vu que ce n’est pas tissulaire et que l’aorte est louche ;)

[Frédéric Schlemmer @fred_schlemmer]

@macromik Hématome retroperitoneal alors… sur tumeur surrénalienne ou infarctus rénal?

[Frédéric Schlemmer @fred_schlemmer]

@macromik K du rein D avec envahissement v. cave inf et pleural de contiguïté?

[ERS publications @ERSpublications]

Substantial variability exists in interstitial lung disease prevalence, risk factors and computed tomography patterns across connective tissue disease subtypes. Further research is required to better understand the complex pathobiology of this disease. https://t.co/TiUd2aOXZ3

[Pulmonology Advisor @PulmAdvisor]

Patients who survive severe-to-critical COVID-19 frequently have significant lung sequelae and residual symptoms for up to 1 year that warrant follow-up. Study in @ERSpublications. @fred_schlemmer @SimonValentinMD #pulmonology #pulmtwitter

https://t.co/vmtzwDXwZP

[The Lancet @TheLancet]

"Here, we report the case of a patient with an idiopathic inflammatory myopathy who was successfully treated with CD19 CAR T cells."

Fabian Müller and colleagues provide a new research letter: https://t.co/cjDE44pyEA

[FSMR - RespiFIL 🫁 @RespiFIL]

🔴 #CPLF2023: l'importance d'explorer de manière plus poussée les DDB idiopathiques par le Dr CATHERINOT Émilie.
@RespiRare_FR @SPLF_SocPneumo
#raredisease #maladiesrares #dilatationsdesbronches

[Frédéric Schlemmer @fred_schlemmer]

So delighted to see the results of our multicentre RE2COVERI study just published online @ERSpublications ! 🙏 to @FduSouffle for support and to all my French colleagues and all patients involved. #GREPI @SPLF_SocPneumo https://t.co/MJteHdYEwE

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🔥MULTICOV RCT🔥
In critically ill adult patients with labo-confirmed SARS-CoV-2 pneumonia,respiratory multiplex PCR/PCT algorithm strategy did NOT affect 28d antibiotics exposure nor major clinical outcomes, as compared with routine practice #IDTwitter
https://t.co/zr2iAnfyeJ

[Frédéric Schlemmer @fred_schlemmer]

@TLHM_MD @farouk_dako @hochhegger @ShravSridhar @marcosmestas @khaledzeid @ladiologist @usfradiology @Placaoplomo @NicoGagelmann Any credits ? A must read, beautiful review on the « Diagnosis of severe respiratory infection in immunocompromised patients » @yourICM @ElieAzoulay5 et al.

[Frédéric Schlemmer @fred_schlemmer]

Poumon de l'ID, prophylaxie pré-CTC orale prolongée, que faire d'un granulome?, PAC du sujet âgé, DDB/MNT...
Tant de sujets de Pneumo-infectiologie passionnants abordés lors des 10èmes journées du GREPI @SPLF_SocPneumo ! à voir (ou à revoir) par ici => https://t.co/PNLAKbCNo7